ASSOCIATION BETWEEN ANTIBODIES TO THE MR-67,000 ISOFORM OF GLUTAMATE-DECARBOXYLASE (GAD) AND TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS WITH COEXISTING AUTOIMMUNE POLYENDOCRINE-SYNDROME TYPE-II

被引：30

作者：

SEISSLER, J ^{[1
]}

BIEG, S ^{[1
]}

YASSIN, N ^{[1
]}

MAUCH, L ^{[1
]}

NORTHEMANN, W ^{[1
]}

BOEHM, BO ^{[1
]}

SCHERBAUM, WA ^{[1
]}

机构：

[1] UNIV LEIPZIG,DEPT INTERNAL MED 3,D-04103 LEIPZIG,GERMANY

来源：

AUTOIMMUNITY | 1994年 / 19卷 / 04期

关键词：

INSULIN-DEPENDENT DIABETES MELLITUS; AUTOIMMUNE POLYENDOCRINE SYNDROME; GLUTAMIC ACID DECARBOXYLASE; AUTOIMMUNITY;

D O I：

10.3109/08916939409071348

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

By using an immunoprecipitation assay, we analysed reactivity of autoantibodies to human recombinant GAD(65) and GAD(67) in sera from patients with autoimmune polyendocrine syndrome Type II (APS II) with and without Type 1 (insulin-dependent) diabetes mellitus (IDDM) compared to patients with organ-specific autoimmunity. Overall antibodies to GAD(65) were correlated with IDDM in all study groups, whereas GAD(67) antibodies were associated with IDDM when APS II coexists. Antibodies to GAD(65) and GAD(67) were detected in 13 (44.8%) and 7 (24.1%) out of 29 APS II patients with IDDM, but in only 4 (13.8%) and 2 (6.9%) out of 29 APS II patients without IDDM, respectively (p < 0.05). In short-standing IDDM (<1 year), antibodies to GAD(67) were significantly more frequent in patients with APS II (5 of 9 [55.6%] subjects) compared to matched diabetic patients without coexisting polyendocrinopathy (1 of 18 [5.6%] subjects) (p < 0.02). The levels of GAD(65) (142+/-90 AU) and GAD(67) antibodies (178+/-95 AU) were significantly higher in patients with polyglandular disease than in patients with isolated IDDM (91+/-85 AU and 93+/-57 AU) (p < 0.02). Interestingly, all 11 GAD(67) antibody positive subjects also had GAD(65) antibodies (p < 0.0001), and in 10 of 11 anti-GAD(67) positive sera the GAD(67) antibodies could be blocked by either GAD(67) or GAD(65), suggesting the presence of cross-reactive autoantibodies. No correlation was observed between GAD antibodies and age, sex or any particular associated autoimmune disease, besides IDDM. GAD antibodies were present in only 1 of 6 (16.7%) patients with APS Type I, in 1 of 26 (3.9%) patients with autoimmune thyroid disease but in none of the patients with Addison's disease (n = 16), pernicious anaemia (n = 7) or normal controls (n = 50). Our data suggest distinct antibody specificities reactive to GAD isoforms in APS II and IDDM, which might reflect different mechanisms of autoimmune response in IDDM with coexisting autoimmune polyendocrine autoimmunity.

引用

页码：231 / 238

页数：8

共 26 条

[1]

Bottazzo G.F., Doniach D., Polyendocrine autoimmunity: an extended concept, Autoimmunity and endocrine disease, pp. 375-403, (1985)

[2]

Bottazzo G.F., Todd I., Mirakian R., Belfiore A., Pujol-Borrell R., Organ-specific autoimmunity. A 1986 overview, Immunol. Rev, 94, pp. 137-169, (1986)

[3]

Muir A., MacLaren N.K., Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis, Endorin. Metab. Clin, 20, pp. 619-643, (1993)

[4]

Banga J.P., Barnett P.S., Mahadevan D., McGregor A.M., Immune recognition of antigen and its relevance to autoimmune disease: recent advances on the molecular level, Europ. J. Clin. Invest, 19, pp. 107-116, (1989)

[5]

Tarn A.C., Thomas J.M., Dean B.M., Et al., Predicting insulin-dependent diabetes, Lancet, pp. 845-850, (1988)

[6]

Riley W.J., MacLaren N.K., Kirscher J., Spillar R.P., Silverstein J.H., Schatz D.A., Et al., A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes, N. Engl. J. Med, 323, pp. 1167-1172, (1990)

[7]

Genovese S., Bonifacio E., McNally J.M., Dean B.M., Wagner R., Bosi E., Et al., Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus, Diabetologia, 35, pp. 385-388, (1992)

[8]

Scherbaum W.A., Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens, Clin. Endocrin, 40, pp. 15-18, (1994)

[9]

Richter W., Seissler J., Northemann W., Wolfahrt S., Meinck H.M., Scherbaum W.A., Cytoplasmic islet cell antibodies recognize distinct antigens in IDDM but not in Stiff Man Syndrome, Diabetes, 42, pp. 1642-1648, (1993)

[10]

Baekkeskov S., Aanstoot A.J., Christgau S., Reetz A., Solimena M., Cascalho M., Et al., Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase, Nature, 347, pp. 151-156, (1990)

← 1 2 3 →